ME
SEC Insider//CIK 0001328625
Mathers Edward T
CIK 000132862517 companiesNEW YORK, NY
Transactions
50
Companies
17
Filings
2
CIK
0001328625
Recent Transactions
- Award
- Exercise/Conversion
- Exercise of In-Money
- Exercise/Conversion
- Tax Payment
- Exercise of In-Money
- Disposition to Issuer
- Exercise/Conversion
- Exercise of In-Money
- Exercise of In-Money
- Award
- Disposition to Issuer
- Award
- Tax Payment
- Exercise of In-Money
- Sale
- Sale
- Exercise of In-Money
- Disposition to Issuer
- Sale
- Disposition to Issuer
- Disposition to Issuer
- Exercise/Conversion
- Disposition to Issuer
- Award
- Award
- Award
- Award
- Award
- Exercise/Conversion
- Exercise/Conversion
- Award
Nonstatutory Stock Option (right to buy)
2025-06-11+45,000→ 45,000 total - Award
- Award
- Award
- Award
- Award
- Purchase
- Purchase
- Purchase
- Conversion
- Conversion
- Conversion
- Conversion
- Award
- Award
- Exercise/Conversion
- Exercise/Conversion
- Award
- Award
Companies
17Akouos, Inc.
Director
Inozyme Pharma, Inc.
Director
- $KRRO
Korro Bio, Inc.
10% Owner
Liquidia Technologies Inc
Director
- $MBX
MBX Biosciences, Inc.
Director, 10% Owner
MEDIMMUNE INC /DE
EVP, Corporate Dev. & Venture
- $MIRM
Mirum Pharmaceuticals, Inc.
Director
- $GLUE
Monte Rosa Therapeutics, Inc.
10% Owner
- $NEUE
NeueHealth, Inc.
Director, 10% Owner
ObsEva SA
Director
- $OKUR
OnKure Therapeutics, Inc.
Director
Ra Pharmaceuticals, Inc.
Director
- $RYTM
RHYTHM PHARMACEUTICALS, INC.
Director
- $SVRA
Savara Inc
10% Owner
- $SNTI
Senti Biosciences, Inc.
Director
- $SYBX
SYNLOGIC, INC.
Director
- $TRVI
Trevi Therapeutics, Inc.
Director
Recent Filings
2Address
104 5TH AVE 19TH FLOOR
NEW YORK, NY, 10011